Massimo Cristofanilli
Northwestern University(US)NewYork–Presbyterian Hospital(US)NewYork–Presbyterian Brooklyn Methodist Hospital(US)Cornell University(US)New York Hospital Queens(US)Lander Institute(IL)Presbyterian Hospital(US)Weill Cornell Medicine(US)Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Publications by Year
Research Areas
Cancer Cells and Metastasis, Cancer Genomics and Diagnostics, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies
Most-Cited Works
- → Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer(2004)4,563 cited
- → Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer(2008)2,876 cited
- → Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy(2005)1,881 cited
- → Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial(2016)1,795 cited
- → Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer(2015)1,569 cited
- → Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System